COVID-19 Information vaccine

Your questions on the COVID-19 vaccine and bleeding disorders

After we posted the official Government guidance giving the COVID-19 vaccine and to people with bleeding disorders on 10 December 2020 we some members have been in touch with their questions. We worked with The Haemophilia Society to cover as many questions as possible. Some answers will take a bit more time so we will publish more as we receive them.

Haemophilia Centres Issue Guidance on COVID Vaccine (28 January 2021)

How is the COVID-19 vaccine is given?

The COVID-19 vaccine is given with a needle into muscle (intramuscularly). Your upper arm (deltoid muscle) will be used. There is not a subcutaneous option available for this vaccine. It’s given as 2 doses, at least 21 days apart.

Has the vaccine been approved for safety?

The vaccine already approved for use in the UK was developed by Pfizer/BioNTech. It has met strict standards of safety, quality and effectiveness set out by the independent Medicines and Healthcare products Regulatory Agency (MHRA). Read about the approved Pfizer/BioNTech vaccine for COVID-19 by MHRA on GOV.UK

COVID-19 vaccine ingredients

The COVID-19 vaccine does not contain any animal products or egg. More details about what the vaccine contains can be found here:

Where can I get the COVID-19 vaccination?

Vaccines will be offered in a range of settings. Some vaccination teams will visit people to administer the vaccine, for example in care homes, others may have to go to your nearest centre. Because some of the vaccine has to be stored in a very low-temperature freezer, you may not be able to get the vaccine in your normal GP surgery.

What precautions should I take?

Talk to your centre, nurse or doctor before you are given the vaccine if you have:

  • a weakened immune system, such as due to HIV infection, or are on a medicine that affects your immune system
  • a bleeding problem, bruise easily or use a medicine to inhibit blood clotting
  • had a serious allergic reaction to a previous vaccine, medicine or food
  • had any problems following previous administration of COVID-19 mRNA Vaccine BNT162b2 such as allergic reaction or breathing problems
  • a severe illness with high fever – However, a mild fever or upper airway infection, like a cold, are not reasons to delay vaccination.

Further guidance about the vaccine can be found here

We encourage anyone with a bleeding disorder who is concerned to discuss the possible implications of receiving the COVID-19 vaccine with their haemophilia centre.

We know there will be more question. If your question isn’t answered then we’d really like to hear it so that we can take it to the appropriate authorities. Just fill in the short form below.

Any information submitted on this form will be held and processed in accordance with the Haemophilia Scotland Privacy Policy.

Leave a Reply

This site uses Akismet to reduce spam. Learn how your comment data is processed.

%d bloggers like this: